Calithera Biosciences Inc (CALA)
0.02
-0.01
(-31.03%)
USD |
OTCM |
Apr 24, 16:00
Calithera Biosciences Total Assets (Quarterly): 28.68M for Dec. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 28.68M |
| September 30, 2022 | 37.08M |
| June 30, 2022 | 45.56M |
| March 31, 2022 | 50.24M |
| December 31, 2021 | 64.76M |
| September 30, 2021 | 89.97M |
| June 30, 2021 | 97.86M |
| March 31, 2021 | 110.66M |
| December 31, 2020 | 125.59M |
| September 30, 2020 | 147.71M |
| June 30, 2020 | 164.93M |
| March 31, 2020 | 149.68M |
| December 31, 2019 | 168.77M |
| September 30, 2019 | 146.32M |
| June 30, 2019 | 166.38M |
| March 31, 2019 | 131.91M |
| December 31, 2018 | 142.72M |
| September 30, 2018 | 147.67M |
| Date | Value |
|---|---|
| June 30, 2018 | 158.98M |
| March 31, 2018 | 178.58M |
| December 31, 2017 | 192.46M |
| September 30, 2017 | 205.54M |
| June 30, 2017 | 214.08M |
| March 31, 2017 | 223.91M |
| December 31, 2016 | 54.80M |
| September 30, 2016 | 58.92M |
| June 30, 2016 | 63.23M |
| March 31, 2016 | 71.56M |
| December 31, 2015 | 75.75M |
| September 30, 2015 | 84.53M |
| June 30, 2015 | 90.75M |
| March 31, 2015 | 96.87M |
| December 31, 2014 | 104.77M |
| September 30, 2014 | 39.64M |
| June 30, 2014 | 30.66M |
| December 31, 2013 | 34.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.68M
Minimum
Dec 2022
168.77M
Maximum
Dec 2019
106.28M
Average
110.66M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.284M |
| Shareholders Equity (Quarterly) | 20.39M |